Friday, September 14, 2007

ASC Research

The Miami Herald has a good story about continuing advances in adult stem cell research. From the article:

Today, stem cells from bone marrow are considered the 'gold standard' for treating leukemia, many immunologists say. But that may be changing.

"I think it's likely that cord blood will become the standard in the future," says Deborah Banker, vice president of the Leukemia & Lymphoma Society.

In 2006, 17.5 percent of the transplants coordinated by the National Marrow Donor Program were from cord blood, said spokeswoman Shauna Sheffer. "That is up 4.2 percent from last year and that number continues growing," she said.


Post a Comment

Subscribe to Post Comments [Atom]

<< Home